After applying for Class D medical device registration under the Hong Kong Medical Device Administrative Control System (MDACS), there are several regulations and requirements that must be adhered to throughout the lifecycle of the device. These obligations ensure ongoing compliance and the continued safety and effectiveness of the medical device. Here’s a detailed overview of the key regulations and requirements to follow:

1. Post-Market Surveillance (PMS)

• Implementation of PMS Plans: After registration, you must implement the Post-Market Surveillance (PMS) plan as outlined in your application. This involves monitoring the device's performance and safety in the market.
• Adverse Event Reporting: Establish a system to collect, investigate, and report any adverse events or incidents associated with the device. Serious adverse events must be reported to the Medical Device Division (MDD) within specified timeframes.

2. Quality Management System (QMS)

• Maintain Compliance: Continuously ensure that your Quality Management System (QMS) remains compliant with ISO 13485 or equivalent standards. This includes regular internal audits, document control, and ongoing training for staff.
• Quality Control: Implement and maintain processes for product quality control, including inspections and testing of devices before they are distributed.

3. Regulatory Compliance

• Regulatory Updates: Stay updated on any changes to regulations, standards, or guidance documents issued by the Hong Kong Department of Health or other relevant authorities. Make necessary adjustments to comply with updated requirements.
• Renewal of Registration: Be aware of the registration renewal process, typically required every five years. Submit any necessary documentation or updated information as part of the renewal application.

4. Record Keeping and Documentation

• Maintain Records: Keep comprehensive records of all post-market surveillance activities, including adverse event reports, customer complaints, and corrective actions taken. These records should be readily available for review by regulatory authorities if requested.
• Documentation Accessibility: Ensure that all technical and quality documents are organized and accessible for audits or inspections.

5. Labeling and Instructions for Use (IFU)

• Compliance with Labeling Requirements: Ensure that all labeling, packaging, and instructions for use (IFU) remain compliant with relevant standards (e.g., ISO 15223). Any changes to the device or its indications must be accurately reflected in the labeling.
• Update IFU as Necessary: Regularly review and update the IFU based on new information or feedback from users to enhance clarity and usability.

6. User Training and Support

• Training Programs: Provide adequate training and support to healthcare professionals and end-users regarding the safe and effective use of the device. This may include in-person training sessions, online resources, and user manuals.
• Feedback Mechanism: Implement a mechanism for gathering feedback from users to identify areas for improvement and address any concerns related to the device.

7. Clinical Evidence Updates

• Continuous Clinical Evaluation: Regularly assess the clinical evidence supporting the safety and efficacy of the device. Update the Clinical Evaluation Report (CER) as new data becomes available or when the device undergoes significant changes.
• Risk Management File Updates: Continuously update the risk management file to reflect any new risks identified through post-market surveillance activities or clinical evaluations.

8. Communication with Regulatory Authorities

• Engage with the MDD: Maintain open communication with the Medical Device Division (MDD). Be prepared to respond promptly to any queries or requests for information regarding the registered device.
• Reporting Changes: Notify the MDD of any significant changes to the device, its intended use, manufacturing processes, or the company’s QMS.

9. Handling Complaints and Recalls

• Complaint Handling Procedures: Establish procedures for handling complaints from users or healthcare professionals. Investigate and document all complaints and implement corrective actions as needed.
• Recall Procedures: Develop and implement procedures for recalling the device if serious safety concerns arise. Ensure timely reporting to the MDD in accordance with regulatory requirements.

Summary

In summary, after applying for Class D medical device registration under the Hong Kong MDACS, manufacturers must adhere to the following:

• Implement and maintain post-market surveillance and adverse event reporting.
• Ensure ongoing compliance with quality management systems and regulatory requirements.
• Keep thorough records and documentation accessible for review.
• Maintain compliance with labeling and instructions for use.
• Provide user training and support while continuously evaluating clinical evidence.
• Engage with regulatory authorities and handle complaints or recalls effectively.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn